aluates Reports

$ 0.0

Automative

Global Hormonal Infertility Treatment Market Research Report 2025

Published Date: 2025-12-08

Report Code: QYRE-Auto-33D10219

Global Hormonal Infertility Treatment Market Research Report 2022

BUY CHAPTERS

Global Hormonal Infertility Treatment Market Research Report 2025

Code: QYRE-Auto-33D10219

Report

2025-12-08

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Merck& Co. Inc

Par Pharmaceutical

TerSera Therapeutics LLC.

Teva Pharmaceuticals

AbbVie

Sanofi

Incepta Pharmaceuticals Ltd.

Serum Institute of India Pvt. Ltd

Merck& Co. Inc

Ferring Pharmaceuticals

Vitrolife AB

Hormonal Infertility Treatment Market Size

The global market for Hormonal Infertility Treatment was valued at US$ 7699 million in the year 2024 and is projected to reach a revised size of US$ 12649 million by 2031, growing at a CAGR of 7.4% during the forecast period.

Hormonal Infertility Treatment Market

Hormonal infertility treatment refers to the systematic intervention for infertility caused by endocrine abnormalities such as ovulation disorders, luteal insufficiency, hyperprolactinemia, or polycystic ovary syndrome (PCOS) resulting from hypothalamic-pituitary-ovarian (or testicular) axis dysfunction. This is achieved through medication to regulate hormone levels (such as gonadotropins Gn, clomiphene, letrozole, GnRH agonists/antagonists), assisted reproductive technologies (such as IUI, IVF), and lifestyle interventions. The upstream of the industry chain includes manufacturers of reproductive hormone raw materials and formulations (such as Merck Serono, Ferring Pharmaceuticals, Livzon Pharmaceutical Group, and Hanyu Pharmaceutical), and diagnostic equipment and reagent companies (sex hormone six-item test, AMH test); the midstream consists of assisted reproductive medical service institutions, encompassing public hospital reproductive centers (such as Peking University Third Hospital and CITIC Xiangya Hospital) and private chain brands (Jinxin Fertility, AIVF, and Becon Medical), providing a full range of services from testing and medication to egg retrieval and embryo transfer; the downstream consists of infertile patients of reproductive age. This sector focuses on high-value-added medical services, with drug gross profit margins ranging from approximately 60% to 85% and assisted reproductive single-cycle services generally reaching 50% to 70%. Leading reproductive hospitals maintain strong profitability by leveraging brand, licensing barriers, and high repeat visit rates, and continue to benefit from the "three-child policy" and the improved fertility support system.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Hormonal Infertility Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormonal Infertility Treatment.

The Hormonal Infertility Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hormonal Infertility Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, by Class and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hormonal Infertility Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hormonal Infertility Treatment Market Report

Report Metric	Details
Report Name	Hormonal Infertility Treatment Market
Accounted market size in year	US$ 7699 million
Forecasted market size in 2031	US$ 12649 million
CAGR	7.4%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	Medications Surgery Assisted Reproductive Technology Others
Segment by Class	Ovulation Disorders Treatment for Thyroid Hormone Abnormalities Treatment for Sex Hormone Abnormalities Other
Segment by Drug Type	Ovulation-inducing Drugs Pituitary-ovarian Axis Regulating Drugs Androgen Regulating Drugs Others
Segment by Application	Hospitals Specialty Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck & Co. Inc, Par Pharmaceutical, TerSera Therapeutics LLC, Teva Pharmaceuticals, AbbVie Inc, Sanofi S.A, Incepta Pharmaceuticals Ltd, Serum Institute of India Pvt. Ltd, Ferring Pharmaceuticals, Vitrolife
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Class etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hormonal Infertility Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Hormonal Infertility Treatment Market growing?

Ans: The Hormonal Infertility Treatment Market witnessing a CAGR of 7.4% during the forecast period 2026-2031.

What is the Hormonal Infertility Treatment Market size in 2031?

Ans: The Hormonal Infertility Treatment Market size in 2031 will be US$ 12649 million.

Who are the main players in the Hormonal Infertility Treatment Market report?

Ans: The main players in the Hormonal Infertility Treatment Market are Merck & Co. Inc, Par Pharmaceutical, TerSera Therapeutics LLC, Teva Pharmaceuticals, AbbVie Inc, Sanofi S.A, Incepta Pharmaceuticals Ltd, Serum Institute of India Pvt. Ltd, Ferring Pharmaceuticals, Vitrolife

What are the Application segmentation covered in the Hormonal Infertility Treatment Market report?

Ans: The Applications covered in the Hormonal Infertility Treatment Market report are Hospitals, Specialty Clinics, Others

What are the Type segmentation covered in the Hormonal Infertility Treatment Market report?

Ans: The Types covered in the Hormonal Infertility Treatment Market report are Ovulation-inducing Drugs, Pituitary-ovarian Axis Regulating Drugs, Androgen Regulating Drugs, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hormonal Infertility Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Medications

1.2.3 Surgery

1.2.4 Assisted Reproductive Technology

1.2.5 Others

1.3 Market by Class

1.3.1 Global Hormonal Infertility Treatment Market Size Growth Rate by Class: 2020 VS 2024 VS 2031

1.3.2 Ovulation Disorders

1.3.3 Treatment for Thyroid Hormone Abnormalities

1.3.4 Treatment for Sex Hormone Abnormalities

1.3.5 Other

1.4 Market by Drug Type

1.4.1 Global Hormonal Infertility Treatment Market Size Growth Rate by Drug Type: 2020 VS 2024 VS 2031

1.4.2 Ovulation-inducing Drugs

1.4.3 Pituitary-ovarian Axis Regulating Drugs

1.4.4 Androgen Regulating Drugs

1.4.5 Others

1.5 Market by Application

1.5.1 Global Hormonal Infertility Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Hospitals

1.5.3 Specialty Clinics

1.5.4 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Hormonal Infertility Treatment Market Perspective (2020-2031)

2.2 Global Hormonal Infertility Treatment Growth Trends by Region

2.2.1 Global Hormonal Infertility Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Hormonal Infertility Treatment Historic Market Size by Region (2020-2025)

2.2.3 Hormonal Infertility Treatment Forecasted Market Size by Region (2026-2031)

2.3 Hormonal Infertility Treatment Market Dynamics

2.3.1 Hormonal Infertility Treatment Industry Trends

2.3.2 Hormonal Infertility Treatment Market Drivers

2.3.3 Hormonal Infertility Treatment Market Challenges

2.3.4 Hormonal Infertility Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hormonal Infertility Treatment Players by Revenue

3.1.1 Global Top Hormonal Infertility Treatment Players by Revenue (2020-2025)

3.1.2 Global Hormonal Infertility Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Top Hormonal Infertility Treatment Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Hormonal Infertility Treatment Revenue

3.4 Global Hormonal Infertility Treatment Market Concentration Ratio

3.4.1 Global Hormonal Infertility Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hormonal Infertility Treatment Revenue in 2024

3.5 Global Key Players of Hormonal Infertility Treatment Head office and Area Served

3.6 Global Key Players of Hormonal Infertility Treatment, Product and Application

3.7 Global Key Players of Hormonal Infertility Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Hormonal Infertility Treatment Breakdown Data by Type

4.1 Global Hormonal Infertility Treatment Historic Market Size by Type (2020-2025)

4.2 Global Hormonal Infertility Treatment Forecasted Market Size by Type (2026-2031)

5 Hormonal Infertility Treatment Breakdown Data by Application

5.1 Global Hormonal Infertility Treatment Historic Market Size by Application (2020-2025)

5.2 Global Hormonal Infertility Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Hormonal Infertility Treatment Market Size (2020-2031)

6.2 North America Hormonal Infertility Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Hormonal Infertility Treatment Market Size by Country (2020-2025)

6.4 North America Hormonal Infertility Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hormonal Infertility Treatment Market Size (2020-2031)

7.2 Europe Hormonal Infertility Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Hormonal Infertility Treatment Market Size by Country (2020-2025)

7.4 Europe Hormonal Infertility Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Hormonal Infertility Treatment Market Size (2020-2031)

8.2 Asia-Pacific Hormonal Infertility Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Hormonal Infertility Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Hormonal Infertility Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Hormonal Infertility Treatment Market Size (2020-2031)

9.2 Latin America Hormonal Infertility Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Hormonal Infertility Treatment Market Size by Country (2020-2025)

9.4 Latin America Hormonal Infertility Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hormonal Infertility Treatment Market Size (2020-2031)

10.2 Middle East & Africa Hormonal Infertility Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Hormonal Infertility Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Hormonal Infertility Treatment Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck & Co. Inc

11.1.1 Merck & Co. Inc Company Details

11.1.2 Merck & Co. Inc Business Overview

11.1.3 Merck & Co. Inc Hormonal Infertility Treatment Introduction

11.1.4 Merck & Co. Inc Revenue in Hormonal Infertility Treatment Business (2020-2025)

11.1.5 Merck & Co. Inc Recent Development

11.2 Par Pharmaceutical

11.2.1 Par Pharmaceutical Company Details

11.2.2 Par Pharmaceutical Business Overview

11.2.3 Par Pharmaceutical Hormonal Infertility Treatment Introduction

11.2.4 Par Pharmaceutical Revenue in Hormonal Infertility Treatment Business (2020-2025)

11.2.5 Par Pharmaceutical Recent Development

11.3 TerSera Therapeutics LLC

11.3.1 TerSera Therapeutics LLC Company Details

11.3.2 TerSera Therapeutics LLC Business Overview

11.3.3 TerSera Therapeutics LLC Hormonal Infertility Treatment Introduction

11.3.4 TerSera Therapeutics LLC Revenue in Hormonal Infertility Treatment Business (2020-2025)

11.3.5 TerSera Therapeutics LLC Recent Development

11.4 Teva Pharmaceuticals

11.4.1 Teva Pharmaceuticals Company Details

11.4.2 Teva Pharmaceuticals Business Overview

11.4.3 Teva Pharmaceuticals Hormonal Infertility Treatment Introduction

11.4.4 Teva Pharmaceuticals Revenue in Hormonal Infertility Treatment Business (2020-2025)

11.4.5 Teva Pharmaceuticals Recent Development

11.5 AbbVie Inc

11.5.1 AbbVie Inc Company Details

11.5.2 AbbVie Inc Business Overview

11.5.3 AbbVie Inc Hormonal Infertility Treatment Introduction

11.5.4 AbbVie Inc Revenue in Hormonal Infertility Treatment Business (2020-2025)

11.5.5 AbbVie Inc Recent Development

11.6 Sanofi S.A

11.6.1 Sanofi S.A Company Details

11.6.2 Sanofi S.A Business Overview

11.6.3 Sanofi S.A Hormonal Infertility Treatment Introduction

11.6.4 Sanofi S.A Revenue in Hormonal Infertility Treatment Business (2020-2025)

11.6.5 Sanofi S.A Recent Development

11.7 Incepta Pharmaceuticals Ltd

11.7.1 Incepta Pharmaceuticals Ltd Company Details

11.7.2 Incepta Pharmaceuticals Ltd Business Overview

11.7.3 Incepta Pharmaceuticals Ltd Hormonal Infertility Treatment Introduction

11.7.4 Incepta Pharmaceuticals Ltd Revenue in Hormonal Infertility Treatment Business (2020-2025)

11.7.5 Incepta Pharmaceuticals Ltd Recent Development

11.8 Serum Institute of India Pvt. Ltd

11.8.1 Serum Institute of India Pvt. Ltd Company Details

11.8.2 Serum Institute of India Pvt. Ltd Business Overview

11.8.3 Serum Institute of India Pvt. Ltd Hormonal Infertility Treatment Introduction

11.8.4 Serum Institute of India Pvt. Ltd Revenue in Hormonal Infertility Treatment Business (2020-2025)

11.8.5 Serum Institute of India Pvt. Ltd Recent Development

11.9 Ferring Pharmaceuticals

11.9.1 Ferring Pharmaceuticals Company Details

11.9.2 Ferring Pharmaceuticals Business Overview

11.9.3 Ferring Pharmaceuticals Hormonal Infertility Treatment Introduction

11.9.4 Ferring Pharmaceuticals Revenue in Hormonal Infertility Treatment Business (2020-2025)

11.9.5 Ferring Pharmaceuticals Recent Development

11.10 Vitrolife

11.10.1 Vitrolife Company Details

11.10.2 Vitrolife Business Overview

11.10.3 Vitrolife Hormonal Infertility Treatment Introduction

11.10.4 Vitrolife Revenue in Hormonal Infertility Treatment Business (2020-2025)

11.10.5 Vitrolife Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck& Co. Inc

Par Pharmaceutical

TerSera Therapeutics LLC.

Teva Pharmaceuticals

AbbVie

Sanofi

Incepta Pharmaceuticals Ltd.

Serum Institute of India Pvt. Ltd

Merck& Co. Inc

Ferring Pharmaceuticals

Vitrolife AB

List of Tables

Table 1. Global Hormonal Infertility Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Medications

Table 3. Key Players of Surgery

Table 4. Key Players of Assisted Reproductive Technology

Table 5. Key Players of Others

Table 6. Global Hormonal Infertility Treatment Market Size Growth Rate by Class (US$ Million): 2020 VS 2024 VS 2031

Table 7. Key Players of Ovulation Disorders

Table 8. Key Players of Treatment for Thyroid Hormone Abnormalities

Table 9. Key Players of Treatment for Sex Hormone Abnormalities

Table 10. Key Players of Other

Table 11. Global Hormonal Infertility Treatment Market Size Growth Rate by Drug Type (US$ Million): 2020 VS 2024 VS 2031

Table 12. Key Players of Ovulation-inducing Drugs

Table 13. Key Players of Pituitary-ovarian Axis Regulating Drugs

Table 14. Key Players of Androgen Regulating Drugs

Table 15. Key Players of Others

Table 16. Global Hormonal Infertility Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Hormonal Infertility Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 18. Global Hormonal Infertility Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 19. Global Hormonal Infertility Treatment Market Share by Region (2020-2025)

Table 20. Global Hormonal Infertility Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 21. Global Hormonal Infertility Treatment Market Share by Region (2026-2031)

Table 22. Hormonal Infertility Treatment Market Trends

Table 23. Hormonal Infertility Treatment Market Drivers

Table 24. Hormonal Infertility Treatment Market Challenges

Table 25. Hormonal Infertility Treatment Market Restraints

Table 26. Global Hormonal Infertility Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 27. Global Hormonal Infertility Treatment Market Share by Players (2020-2025)

Table 28. Global Top Hormonal Infertility Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Infertility Treatment as of 2024)

Table 29. Ranking of Global Top Hormonal Infertility Treatment Companies by Revenue (US$ Million) in 2024

Table 30. Global 5 Largest Players Market Share by Hormonal Infertility Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 31. Global Key Players of Hormonal Infertility Treatment, Headquarters and Area Served

Table 32. Global Key Players of Hormonal Infertility Treatment, Product and Application

Table 33. Global Key Players of Hormonal Infertility Treatment, Date of Enter into This Industry

Table 34. Mergers & Acquisitions, Expansion Plans

Table 35. Global Hormonal Infertility Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 36. Global Hormonal Infertility Treatment Revenue Market Share by Type (2020-2025)

Table 37. Global Hormonal Infertility Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 38. Global Hormonal Infertility Treatment Revenue Market Share by Type (2026-2031)

Table 39. Global Hormonal Infertility Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 40. Global Hormonal Infertility Treatment Revenue Market Share by Application (2020-2025)

Table 41. Global Hormonal Infertility Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 42. Global Hormonal Infertility Treatment Revenue Market Share by Application (2026-2031)

Table 43. North America Hormonal Infertility Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. North America Hormonal Infertility Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. North America Hormonal Infertility Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Europe Hormonal Infertility Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Europe Hormonal Infertility Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 48. Europe Hormonal Infertility Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 49. Asia-Pacific Hormonal Infertility Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 50. Asia-Pacific Hormonal Infertility Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 51. Asia-Pacific Hormonal Infertility Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 52. Latin America Hormonal Infertility Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 53. Latin America Hormonal Infertility Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 54. Latin America Hormonal Infertility Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 55. Middle East & Africa Hormonal Infertility Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 56. Middle East & Africa Hormonal Infertility Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 57. Middle East & Africa Hormonal Infertility Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 58. Merck & Co. Inc Company Details

Table 59. Merck & Co. Inc Business Overview

Table 60. Merck & Co. Inc Hormonal Infertility Treatment Product

Table 61. Merck & Co. Inc Revenue in Hormonal Infertility Treatment Business (2020-2025) & (US$ Million)

Table 62. Merck & Co. Inc Recent Development

Table 63. Par Pharmaceutical Company Details

Table 64. Par Pharmaceutical Business Overview

Table 65. Par Pharmaceutical Hormonal Infertility Treatment Product

Table 66. Par Pharmaceutical Revenue in Hormonal Infertility Treatment Business (2020-2025) & (US$ Million)

Table 67. Par Pharmaceutical Recent Development

Table 68. TerSera Therapeutics LLC Company Details

Table 69. TerSera Therapeutics LLC Business Overview

Table 70. TerSera Therapeutics LLC Hormonal Infertility Treatment Product

Table 71. TerSera Therapeutics LLC Revenue in Hormonal Infertility Treatment Business (2020-2025) & (US$ Million)

Table 72. TerSera Therapeutics LLC Recent Development

Table 73. Teva Pharmaceuticals Company Details

Table 74. Teva Pharmaceuticals Business Overview

Table 75. Teva Pharmaceuticals Hormonal Infertility Treatment Product

Table 76. Teva Pharmaceuticals Revenue in Hormonal Infertility Treatment Business (2020-2025) & (US$ Million)

Table 77. Teva Pharmaceuticals Recent Development

Table 78. AbbVie Inc Company Details

Table 79. AbbVie Inc Business Overview

Table 80. AbbVie Inc Hormonal Infertility Treatment Product

Table 81. AbbVie Inc Revenue in Hormonal Infertility Treatment Business (2020-2025) & (US$ Million)

Table 82. AbbVie Inc Recent Development

Table 83. Sanofi S.A Company Details

Table 84. Sanofi S.A Business Overview

Table 85. Sanofi S.A Hormonal Infertility Treatment Product

Table 86. Sanofi S.A Revenue in Hormonal Infertility Treatment Business (2020-2025) & (US$ Million)

Table 87. Sanofi S.A Recent Development

Table 88. Incepta Pharmaceuticals Ltd Company Details

Table 89. Incepta Pharmaceuticals Ltd Business Overview

Table 90. Incepta Pharmaceuticals Ltd Hormonal Infertility Treatment Product

Table 91. Incepta Pharmaceuticals Ltd Revenue in Hormonal Infertility Treatment Business (2020-2025) & (US$ Million)

Table 92. Incepta Pharmaceuticals Ltd Recent Development

Table 93. Serum Institute of India Pvt. Ltd Company Details

Table 94. Serum Institute of India Pvt. Ltd Business Overview

Table 95. Serum Institute of India Pvt. Ltd Hormonal Infertility Treatment Product

Table 96. Serum Institute of India Pvt. Ltd Revenue in Hormonal Infertility Treatment Business (2020-2025) & (US$ Million)

Table 97. Serum Institute of India Pvt. Ltd Recent Development

Table 98. Ferring Pharmaceuticals Company Details

Table 99. Ferring Pharmaceuticals Business Overview

Table 100. Ferring Pharmaceuticals Hormonal Infertility Treatment Product

Table 101. Ferring Pharmaceuticals Revenue in Hormonal Infertility Treatment Business (2020-2025) & (US$ Million)

Table 102. Ferring Pharmaceuticals Recent Development

Table 103. Vitrolife Company Details

Table 104. Vitrolife Business Overview

Table 105. Vitrolife Hormonal Infertility Treatment Product

Table 106. Vitrolife Revenue in Hormonal Infertility Treatment Business (2020-2025) & (US$ Million)

Table 107. Vitrolife Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Hormonal Infertility Treatment Picture

Figure 2. Global Hormonal Infertility Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Hormonal Infertility Treatment Market Share by Type: 2024 VS 2031

Figure 4. Medications Features

Figure 5. Surgery Features

Figure 6. Assisted Reproductive Technology Features

Figure 7. Others Features

Figure 8. Global Hormonal Infertility Treatment Market Size Comparison by Class (2020-2031) & (US$ Million)

Figure 9. Ovulation Disorders Features

Figure 10. Treatment for Thyroid Hormone Abnormalities Features

Figure 11. Treatment for Sex Hormone Abnormalities Features

Figure 12. Other Features

Figure 13. Global Hormonal Infertility Treatment Market Size Comparison by Drug Type (2020-2031) & (US$ Million)

Figure 14. Ovulation-inducing Drugs Features

Figure 15. Pituitary-ovarian Axis Regulating Drugs Features

Figure 16. Androgen Regulating Drugs Features

Figure 17. Others Features

Figure 18. Global Hormonal Infertility Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 19. Global Hormonal Infertility Treatment Market Share by Application: 2024 VS 2031

Figure 20. Hospitals Case Studies

Figure 21. Specialty Clinics Case Studies

Figure 22. Others Case Studies

Figure 23. Hormonal Infertility Treatment Report Years Considered

Figure 24. Global Hormonal Infertility Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 25. Global Hormonal Infertility Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 26. Global Hormonal Infertility Treatment Market Share by Region: 2024 VS 2031

Figure 27. Global Hormonal Infertility Treatment Market Share by Players in 2024

Figure 28. Global Hormonal Infertility Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 29. The Top 10 and 5 Players Market Share by Hormonal Infertility Treatment Revenue in 2024

Figure 30. North America Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. North America Hormonal Infertility Treatment Market Share by Country (2020-2031)

Figure 32. United States Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Canada Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Europe Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Europe Hormonal Infertility Treatment Market Share by Country (2020-2031)

Figure 36. Germany Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. France Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. U.K. Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Italy Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Russia Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Ireland Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Asia-Pacific Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Asia-Pacific Hormonal Infertility Treatment Market Share by Region (2020-2031)

Figure 44. China Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Japan Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. South Korea Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Southeast Asia Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. India Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Australia & New Zealand Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Latin America Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Latin America Hormonal Infertility Treatment Market Share by Country (2020-2031)

Figure 52. Mexico Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Brazil Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Middle East & Africa Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Middle East & Africa Hormonal Infertility Treatment Market Share by Country (2020-2031)

Figure 56. Israel Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Saudi Arabia Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. UAE Hormonal Infertility Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. Merck & Co. Inc Revenue Growth Rate in Hormonal Infertility Treatment Business (2020-2025)

Figure 60. Par Pharmaceutical Revenue Growth Rate in Hormonal Infertility Treatment Business (2020-2025)

Figure 61. TerSera Therapeutics LLC Revenue Growth Rate in Hormonal Infertility Treatment Business (2020-2025)

Figure 62. Teva Pharmaceuticals Revenue Growth Rate in Hormonal Infertility Treatment Business (2020-2025)

Figure 63. AbbVie Inc Revenue Growth Rate in Hormonal Infertility Treatment Business (2020-2025)

Figure 64. Sanofi S.A Revenue Growth Rate in Hormonal Infertility Treatment Business (2020-2025)

Figure 65. Incepta Pharmaceuticals Ltd Revenue Growth Rate in Hormonal Infertility Treatment Business (2020-2025)

Figure 66. Serum Institute of India Pvt. Ltd Revenue Growth Rate in Hormonal Infertility Treatment Business (2020-2025)

Figure 67. Ferring Pharmaceuticals Revenue Growth Rate in Hormonal Infertility Treatment Business (2020-2025)

Figure 68. Vitrolife Revenue Growth Rate in Hormonal Infertility Treatment Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Menopause Hormonal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Assisted Reproductive Technology Drugs Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Amenorrhea Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Menopause Hormonal Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Assisted Reproduction Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Reproductive and Fertility Diagnosis Market Research Report 2025

Global Drugs for Hormonal Replacement Therapy Market Research Report 2024

Global Gravid Treatment Market Research Report 2024

Rare Endocrine Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Growth Hormone Disorder Treatment Market Research Report 2025

Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Male Menopause Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Adrenogenital Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hair Loss Treatment for Man Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nocturia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ovulation Induction Market Research Report 2025

Global Genitourinary System Treatment Market Research Report 2024

Global Polycystic Ovary Syndrome PCOS Drugs Market Research Report 2024

Estrogen Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions